<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">33498186</PMID><DateCompleted><Year>2021</Year><Month>04</Month><Day>07</Day></DateCompleted><DateRevised><Year>2021</Year><Month>04</Month><Day>07</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1422-0067</ISSN><JournalIssue CitedMedium="Internet"><Volume>22</Volume><Issue>3</Issue><PubDate><Year>2021</Year><Month>Jan</Month><Day>20</Day></PubDate></JournalIssue><Title>International journal of molecular sciences</Title><ISOAbbreviation>Int J Mol Sci</ISOAbbreviation></Journal><ArticleTitle>Little Helpers or Mean Rogue-Role of Microglia in Animal Models of Amyotrophic Lateral Sclerosis.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">993</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/ijms22030993</ELocationID><Abstract><AbstractText>Amyotrophic lateral sclerosis (ALS) is one of the most common neurodegenerative diseases, causing degeneration of both upper and lower motor neurons in the central nervous system (CNS). ALS patients suffer from hyperreflexia, spasticity, paralysis and muscle atrophy and typically die due to respiratory failure 1-5 years after disease onset. In addition to the degeneration of motor neurons on the cellular level, ALS has been associated with neuroinflammation, such as microgliosis. Microglial activation in ALS can either be protective or degenerative to the neurons. Among others, mutations in superoxide dismutase 1 (SOD1), chromosome 9 open reading frame 72 (C9Orf72), transactive response DNA binding protein (TDP) 43 and vacuolar protein sorting-associated protein 54 (VPS54) genes have been associated with ALS. Here, we describe the dual role and functionality of microglia in four different in vivo ALS models and search for the lowest common denominator with respect to the role of microglia in the highly heterogeneous disease of ALS.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Cihankaya</LastName><ForeName>Hilal</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Cytology, Institute of Anatomy, Ruhr-University Bochum, D-44801 Bochum, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>International Graduate School of Neuroscience (IGSN), Ruhr-University Bochum, D-44801 Bochum, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Theiss</LastName><ForeName>Carsten</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0001-7983-0143</Identifier><AffiliationInfo><Affiliation>Department of Cytology, Institute of Anatomy, Ruhr-University Bochum, D-44801 Bochum, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>International Graduate School of Neuroscience (IGSN), Ruhr-University Bochum, D-44801 Bochum, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Matschke</LastName><ForeName>Veronika</ForeName><Initials>V</Initials><Identifier Source="ORCID">0000-0001-9717-4485</Identifier><AffiliationInfo><Affiliation>Department of Cytology, Institute of Anatomy, Ruhr-University Bochum, D-44801 Bochum, Germany.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>01</Month><Day>20</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Mol Sci</MedlineTA><NlmUniqueID>101092791</NlmUniqueID><ISSNLinking>1422-0067</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000073885">C9orf72 Protein</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004268">DNA-Binding Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C578077">TDP-43 protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D033921">Vesicular Transport Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C486750">Vps54 protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="D000072105">Superoxide Dismutase-1</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000073885" MajorTopicYN="N">C9orf72 Protein</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004268" MajorTopicYN="N">DNA-Binding Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="Y">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017628" MajorTopicYN="N">Microglia</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000072105" MajorTopicYN="N">Superoxide Dismutase-1</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D033921" MajorTopicYN="N">Vesicular Transport Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ALS</Keyword><Keyword MajorTopicYN="N">chromosome 9 open reading frame 72</Keyword><Keyword MajorTopicYN="N">microglial activation</Keyword><Keyword MajorTopicYN="N">neuroinflammation</Keyword><Keyword MajorTopicYN="N">superoxide dismutase 1</Keyword><Keyword MajorTopicYN="N">transactive response DNA binding protein 43</Keyword><Keyword MajorTopicYN="N">wobbler mouse</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>12</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>1</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>1</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>1</Month><Day>27</Day><Hour>1</Hour><Minute>5</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>1</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>4</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33498186</ArticleId><ArticleId IdType="pmc">PMC7863915</ArticleId><ArticleId IdType="doi">10.3390/ijms22030993</ArticleId><ArticleId IdType="pii">ijms22030993</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Ferraiuolo L., Kirby J., Grierson A.J., Sendtner M., Shaw P.J. Molecular Pathways of Motor Neuron Injury in Amyotrophic Lateral Sclerosis. Nat. Rev. Neurol. 2011;7:616&#x2013;630. doi: 10.1038/nrneurol.2011.152.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneurol.2011.152</ArticleId><ArticleId IdType="pubmed">22051914</ArticleId></ArticleIdList></Reference><Reference><Citation>Robberecht W., Philips T. The Changing Scene of Amyotrophic Lateral Sclerosis. Nat. Rev. Neurosci. 2013 doi: 10.1038/nrn3430.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrn3430</ArticleId><ArticleId IdType="pubmed">23463272</ArticleId></ArticleIdList></Reference><Reference><Citation>Bruijn L.I., Miller T.M., Cleveland D.W. Unraveling the Mechanisms Involved in Motor Neuron Degeneration in Als. Annu. Rev. Neurosci. 2004;14:248&#x2013;264. doi: 10.1146/annurev.neuro.27.070203.144244.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev.neuro.27.070203.144244</ArticleId><ArticleId IdType="pubmed">15217349</ArticleId></ArticleIdList></Reference><Reference><Citation>Philips T., Rothstein J.D. Glial Cells in Amyotrophic Lateral Sclerosis. Exp. Neurol. 2014;262:111&#x2013;120. doi: 10.1016/j.expneurol.2014.05.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2014.05.015</ArticleId><ArticleId IdType="pmc">PMC4241182</ArticleId><ArticleId IdType="pubmed">24859452</ArticleId></ArticleIdList></Reference><Reference><Citation>Polazzi E., Monti B. Microglia and Neuroprotection: From in Vitro Studies to Therapeutic Applications. Prog. Neurobiol. 2010;92:293&#x2013;315. doi: 10.1016/j.pneurobio.2010.06.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pneurobio.2010.06.009</ArticleId><ArticleId IdType="pubmed">20609379</ArticleId></ArticleIdList></Reference><Reference><Citation>Imai Y., Kohsaka S. Intracellular Signaling in M-CSF-Induced Microglia Activation: Role of Iba1. Glia. 2002;40:164&#x2013;174. doi: 10.1002/glia.10149.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/glia.10149</ArticleId><ArticleId IdType="pubmed">12379904</ArticleId></ArticleIdList></Reference><Reference><Citation>Panni R.Z., Herndon J.M., Zuo C., Hegde S., Hogg G.D., Knolhoff B.L., Breden M.A., Li X., Krisnawan V.E., Khan S.Q., et al. Agonism of CD11b Reprograms Innate Immunity to Sensitize Pancreatic Cancer to Immunotherapies. Sci. Transl. Med. 2019;11:499. doi: 10.1126/scitranslmed.aau9240.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.aau9240</ArticleId><ArticleId IdType="pmc">PMC7197026</ArticleId><ArticleId IdType="pubmed">31270275</ArticleId></ArticleIdList></Reference><Reference><Citation>Chistiakov D.A., Killingsworth M.C., Myasoedova V.A., Orekhov A.N., Bobryshev Y.V. CD68/Macrosialin: Not Just a Histochemical Marker. Lab. Investig. 2017;97:4&#x2013;12. doi: 10.1038/labinvest.2016.116.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/labinvest.2016.116</ArticleId><ArticleId IdType="pubmed">27869795</ArticleId></ArticleIdList></Reference><Reference><Citation>Silverstein R.L., Febbraio M. CD36, a Scavenger Receptor Involved in Immunity, Metabolism, Angiogenesis, and Behavior. Sci. Signal. 2009;2 doi: 10.1126/scisignal.272re3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scisignal.272re3</ArticleId><ArticleId IdType="pmc">PMC2811062</ArticleId><ArticleId IdType="pubmed">19471024</ArticleId></ArticleIdList></Reference><Reference><Citation>Benveniste E.N., Nguyen V.T., Wesemann D.R. Molecular Regulation of CD40 Gene Expression in Macrophages and Microglia. Brain Behav. Immun. 2004;18:7&#x2013;12. doi: 10.1016/j.bbi.2003.09.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2003.09.001</ArticleId><ArticleId IdType="pubmed">14651941</ArticleId></ArticleIdList></Reference><Reference><Citation>Cunha C., Santos C., Gomes C., Fernandes A., Correia A.M., Sebasti&#xe3;o A.M., Vaz A.R., Brites D. Downregulated Glia Interplay and Increased MiRNA-155 as Promising Markers to Track ALS at an Early Stage. Mol. Neurobiol. 2018;55:4207&#x2013;4224. doi: 10.1007/s12035-017-0631-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-017-0631-2</ArticleId><ArticleId IdType="pubmed">28612258</ArticleId></ArticleIdList></Reference><Reference><Citation>Johann S., Heitzer M., Kanagaratnam M., Goswami A., Rizo T., Weis J., Troost D., Beyer C. NLRP3 Inflammasome Is Expressed by Astrocytes in the SOD1 Mouse Model of ALS and in Human Sporadic ALS Patients. Glia. 2015;63:2260&#x2013;2273. doi: 10.1002/glia.22891.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/glia.22891</ArticleId><ArticleId IdType="pubmed">26200799</ArticleId></ArticleIdList></Reference><Reference><Citation>Maniatis S., &#xc4;ij&#xf6; T., Vickovic S., Braine C., Kang K., Mollbrink A., Fagegaltier D., Andrusivov&#xe1; &#x17d;., Saarenp&#xe4;&#xe4; S., Saiz-Castro G., et al. Spatiotemporal Dynamics of Molecular Pathology in Amyotrophic Lateral Sclerosis. Science. 2019;364:89&#x2013;93. doi: 10.1126/science.aav9776.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aav9776</ArticleId><ArticleId IdType="pubmed">30948552</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiarotto G.B., Cartarozzi L.P., Perez M., Biscola N.P., Spejo A.B., Gubert F., Franc&#x105; Junior M., Mendez-Otero R., De Oliveira A.L.R. Tempol Improves Neuroinflammation and Delays Motor Dysfunction in a Mouse Model (SOD1G93A) of ALS. J. Neuroinflamm. 2019;16 doi: 10.1186/s12974-019-1598-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-019-1598-x</ArticleId><ArticleId IdType="pmc">PMC6857328</ArticleId><ArticleId IdType="pubmed">31727149</ArticleId></ArticleIdList></Reference><Reference><Citation>Romer S.H., Seedle K., Turner S.M., Li J., Baccei M.L., Crone S.A. Accessory Respiratory Muscles Enhance Ventilation in ALS Model Mice and Are Activated by Excitatory V2a Neurons. Exp. Neurol. 2017;287:192&#x2013;204. doi: 10.1016/j.expneurol.2016.05.033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2016.05.033</ArticleId><ArticleId IdType="pubmed">27456268</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonifacino T., Cattaneo L., Gallia E., Puliti A., Melone M., Provenzano F., Bossi S., Musante I., Usai C., Conti F., et al. In-Vivo Effects of Knocking-down Metabotropic Glutamate Receptor 5 in the SOD1G93A Mouse Model of Amyotrophic Lateral Sclerosis. Neuropharmacology. 2017;123:433&#x2013;445. doi: 10.1016/j.neuropharm.2017.06.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuropharm.2017.06.020</ArticleId><ArticleId IdType="pubmed">28645622</ArticleId></ArticleIdList></Reference><Reference><Citation>Ringer C., Weihe E., Sch&#xfc;tz B. SOD1G93A Mutant Mice Develop a Neuroinflammation-Independent Dendropathy in Excitatory Neuronal Subsets of the Olfactory Bulb and Retina. J. Neuropathol. Exp. Neurol. 2017;76:769&#x2013;778. doi: 10.1093/jnen/nlx057.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jnen/nlx057</ArticleId><ArticleId IdType="pubmed">28859334</ArticleId></ArticleIdList></Reference><Reference><Citation>Kook M.G., Choi S.W., Seo Y., Kim D.W., Song B.K., Son I., Kim S., Kang K.S. KCHO-1, a Novel Herbal Anti-Inflammatory Compound, Attenuates Oxidative Stress in an Animal Model of Amyotrophic Lateral Sclerosis. J. Vet. Sci. 2017;18:487&#x2013;497. doi: 10.4142/jvs.2017.18.4.487.</Citation><ArticleIdList><ArticleId IdType="doi">10.4142/jvs.2017.18.4.487</ArticleId><ArticleId IdType="pmc">PMC5746442</ArticleId><ArticleId IdType="pubmed">28385005</ArticleId></ArticleIdList></Reference><Reference><Citation>Sereddenina T., Nayernia Z., Sorce S., Maghzal G.J., Filippova A., Ling S.-C., Basset O., Plastre O., Daali Y., Rushing E.J., et al. Evaluation of NADPH Oxidases as Drug Targets in a Mouse Model of Familial Amyotrophic Lateral Sclerosis. Free Radic. Biol. Med. 2016;97:95&#x2013;108. doi: 10.1016/j.freeradbiomed.2016.05.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.freeradbiomed.2016.05.016</ArticleId><ArticleId IdType="pubmed">27212019</ArticleId></ArticleIdList></Reference><Reference><Citation>Sheean R.K., McKay F.C., Cretney E., Bye C.R., Perera N.D., Tomas D., Weston R.A., Scheller K.J., Djouma E., Menon P., et al. Association of Regulatory T-Cell Expansion with Progression of Amyotrophic Lateral Sclerosis. JAMA Neurol. 2018;75:681. doi: 10.1001/jamaneurol.2018.0035.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2018.0035</ArticleId><ArticleId IdType="pmc">PMC5885208</ArticleId><ArticleId IdType="pubmed">29507931</ArticleId></ArticleIdList></Reference><Reference><Citation>Solomonov Y., Hadad N., Levy R. Reduction of Cytosolic Phospholipase A2&#x3b1; Upregulation Delays the Onset of Symptoms in SOD1G93A Mouse Model of Amyotrophic Lateral Sclerosis. J. Neuroinflamm. 2016;13:134. doi: 10.1186/s12974-016-0602-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-016-0602-y</ArticleId><ArticleId IdType="pmc">PMC4888471</ArticleId><ArticleId IdType="pubmed">27250836</ArticleId></ArticleIdList></Reference><Reference><Citation>Rabinovich-Nikitin I., Ezra A., Barbiro B., Rabinovich-Toidman P., Solomon B. Chronic Administration of AMD3100 Increases Survival and Alleviates Pathology in SOD1G93A Mice Model of ALS. J. Neuroinflamm. 2016;13:1. doi: 10.1186/s12974-016-0587-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-016-0587-6</ArticleId><ArticleId IdType="pmc">PMC4882847</ArticleId><ArticleId IdType="pubmed">27230771</ArticleId></ArticleIdList></Reference><Reference><Citation>Cocozza G., di Castro M.A., Carbonari L., Grimaldi A., Antonangeli F., Garofalo S., Porzia A., Madonna M., Mainiero F., Santoni A., et al. Ca2+ -Activated K+ Channels Modulate Microglia Affecting Motor Neuron Survival in HSOD1 G93A Mice. Brain Behav. Immun. 2018;73:584&#x2013;595. doi: 10.1016/j.bbi.2018.07.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2018.07.002</ArticleId><ArticleId IdType="pmc">PMC6129409</ArticleId><ArticleId IdType="pubmed">29981425</ArticleId></ArticleIdList></Reference><Reference><Citation>Apolloni S., Fabbrizio P., Amadio S., Volonte C. Actions of the Antihistaminergic Clemastine on Presymptomatic SOD1-G93A Mice Ameliorate ALS Disease Progression. J. Neuroinflamm. 2016;13:191. doi: 10.1186/s12974-016-0658-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-016-0658-8</ArticleId><ArticleId IdType="pmc">PMC4994328</ArticleId><ArticleId IdType="pubmed">27549088</ArticleId></ArticleIdList></Reference><Reference><Citation>Korhonen P., Pollari E., Kanninen K.M., Savchenko E., Lehtonen &#x160;., Wojciechowski S., Pomeshchik Y., Van Den Bosch L., Goldsteins G., Koistinaho J., et al. Long-Term Interleukin-33 Treatment Delays Disease Onset and Alleviates Astrocytic Activation in a Transgenic Mouse Model of Amyotrophic Lateral Sclerosis. IBRO Rep. 2019;6:74&#x2013;86. doi: 10.1016/j.ibror.2019.01.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ibror.2019.01.005</ArticleId><ArticleId IdType="pmc">PMC6348738</ArticleId><ArticleId IdType="pubmed">30705990</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeldich E., Di Chen C., Boden E., Howat B., Nasse J.S., Zeldich D., Lambert A.G., Yuste A., Cherry J.D., Mathias R.M., et al. Klotho Is Neuroprotective in the Superoxide Dismutase (SOD1G93A) Mouse Model of ALS. J. Mol. Neurosci. 2019;69:264&#x2013;285. doi: 10.1007/s12031-019-01356-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12031-019-01356-2</ArticleId><ArticleId IdType="pmc">PMC7008951</ArticleId><ArticleId IdType="pubmed">31250273</ArticleId></ArticleIdList></Reference><Reference><Citation>El Oussini H., Bayer H., Scekic-Zahirovic J., Vercruysse P., Sinniger J., Dirrig-Grosch S., Dieterl&#xe9; S., Echaniz-Laguna A., Larmet Y., M&#xfc;ller K., et al. Serotonin 2B Receptor Slows Disease Progression and Prevents Degeneration of Spinal Cord Mononuclear Phagocytes in Amyotrophic Lateral Sclerosis. Acta Neuropathol. 2016;131:465&#x2013;480. doi: 10.1007/s00401-016-1534-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-016-1534-4</ArticleId><ArticleId IdType="pubmed">26744351</ArticleId></ArticleIdList></Reference><Reference><Citation>Cai M.D., Yang E.J. Gamisoyo-San Ameliorates Neuroinflammation in the Spinal Cord of HSOD1G93A Transgenic Mice. Mediat. Inflamm. 2018 doi: 10.1155/2018/5897817.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2018/5897817</ArticleId><ArticleId IdType="pmc">PMC6036813</ArticleId><ArticleId IdType="pubmed">30046279</ArticleId></ArticleIdList></Reference><Reference><Citation>Fellner A., Barhum Y., Angel A., Perets N., Steiner I., Offen D., Lev N. Toll-Like Receptor-4 Inhibitor TAK-242 Attenuates Motor Dysfunction and Spinal Cord Pathology in an Amyotrophic Lateral Sclerosis Mouse Model. Int. J. Mol. Sci. 2017;18:1666. doi: 10.3390/ijms18081666.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms18081666</ArticleId><ArticleId IdType="pmc">PMC5578056</ArticleId><ArticleId IdType="pubmed">28763002</ArticleId></ArticleIdList></Reference><Reference><Citation>Matsye P., Zheng L., Si Y., Kim S., Luo W., Crossman D.K., Bratcher P.E., King P.H. HuR Promotes the Molecular Signature and Phenotype of Activated Microglia: Implications for Amyotrophic Lateral Sclerosis and Other Neurodegenerative Diseases. Glia. 2017;65:945&#x2013;963. doi: 10.1002/glia.23137.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/glia.23137</ArticleId><ArticleId IdType="pubmed">28300326</ArticleId></ArticleIdList></Reference><Reference><Citation>LaClair K.D., Zhou Q., Michaelsen M., Wefers B., Brill M.S., Janjic A., Rathkolb B., Farny D., Cygan M., de Angelis M.H., et al. Congenic Expression of Poly-GA but Not Poly-PR in Mice Triggers Selective Neuron Loss and Interferon Responses Found in C9orf72 ALS. Acta Neuropathol. 2020;140:121&#x2013;142. doi: 10.1007/s00401-020-02176-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-020-02176-0</ArticleId><ArticleId IdType="pmc">PMC7360660</ArticleId><ArticleId IdType="pubmed">32562018</ArticleId></ArticleIdList></Reference><Reference><Citation>Schludi M.H., Becker L., Garrett L., Gendron T.F., Zhou Q., Schreiber F., Popper B., Dimou L., Strom T.M., Winkelmann J., et al. Spinal Poly-GA Inclusions in a C9orf72 Mouse Model Trigger Motor Deficits and Inflammation without Neuron Loss. Acta Neuropathol. 2017;134:241&#x2013;254. doi: 10.1007/s00401-017-1711-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-017-1711-0</ArticleId><ArticleId IdType="pmc">PMC5508040</ArticleId><ArticleId IdType="pubmed">28409281</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou Q., Mareljic N., Michaelsen M., Parhizkar S., Heindl S., Nuscher B., Farny D., Czuppa M., Schludi C., Graf A., et al. Active Poly-GA Vaccination Prevents Microglia Activation and Motor Deficits in a C9orf72 Mouse Model. EMBO Mol. Med. 2020;12 doi: 10.15252/emmm.201910919.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/emmm.201910919</ArticleId><ArticleId IdType="pmc">PMC7005532</ArticleId><ArticleId IdType="pubmed">31858749</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y.J., Gendron T.F., Ebbert M.T.W., O&#x2019;Raw A.D., Yue M., Jansen-West K., Zhang X., Prudencio M., Chew J., Cook C.N., et al. Poly(GR) Impairs Protein Translation and Stress Granule Dynamics in C9orf72-Associated Frontotemporal Dementia and Amyotrophic Lateral Sclerosis. Nat. Med. 2018;24:1136&#x2013;1142. doi: 10.1038/s41591-018-0071-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-018-0071-1</ArticleId><ArticleId IdType="pmc">PMC6520050</ArticleId><ArticleId IdType="pubmed">29942091</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee J.D., Levin S.C., Willis E.F., Li R., Woodruff T.M., Noakes P.G. Complement Components Are Upregulated and Correlate with Disease Progression in the TDP-43 Q331K Mouse Model of Amyotrophic Lateral Sclerosis. J. Neuroinflamm. 2018;15 doi: 10.1186/s12974-018-1217-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-018-1217-2</ArticleId><ArticleId IdType="pmc">PMC5984816</ArticleId><ArticleId IdType="pubmed">29859100</ArticleId></ArticleIdList></Reference><Reference><Citation>Jara J.H., Gautam M., Kocak N., Xie E.F., Mao Q., Bigio E.H., &#xd6;zdinler P.H. MCP1-CCR2 and Neuroinflammation in the ALS Motor Cortex with TDP-43 Pathology. J. Neuroinflamm. 2019;16:196. doi: 10.1186/s12974-019-1589-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-019-1589-y</ArticleId><ArticleId IdType="pmc">PMC6822373</ArticleId><ArticleId IdType="pubmed">31666087</ArticleId></ArticleIdList></Reference><Reference><Citation>Perera N.D., Sheean R.K., Crouch P.J., White A.R., Horne M.K., Turner B.J. Enhancing Survival Motor Neuron Expression Extends Lifespan and Attenuates Neurodegeneration in Mutant TDP-43 Mice. Hum. Mol. Genet. 2016;25:4080&#x2013;4093. doi: 10.1093/hmg/ddw247.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddw247</ArticleId><ArticleId IdType="pubmed">27466204</ArticleId></ArticleIdList></Reference><Reference><Citation>Dahlke C., Saberi D., Ott B., Brand-Saberi B., Schmitt-John T., Theiss C. Inflammation and Neuronal Death in the Motor Cortex of the Wobbler Mouse, an ALS Animal Model. J. Neuroinflamm. 2015;12 doi: 10.1186/s12974-015-0435-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-015-0435-0</ArticleId><ArticleId IdType="pmc">PMC4657283</ArticleId><ArticleId IdType="pubmed">26597538</ArticleId></ArticleIdList></Reference><Reference><Citation>Saberi D., Ott B., Dahlke C., Matschke V., Schmitt-John T., Theiss C. The Spatiotemporal Pattern of Degeneration in the Cerebellum of the Wobbler Mouse. J. Neuropathol. Exp. Neurol. 2016;75:347&#x2013;357. doi: 10.1093/jnen/nlw005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jnen/nlw005</ArticleId><ArticleId IdType="pubmed">26945034</ArticleId></ArticleIdList></Reference><Reference><Citation>Bigini P., Repici M., Cantarella G., Fumagalli E., Barbera S., Cagnotto A., De Luigi A., Tonelli R., Bernardini R., Borsello T., et al. Recombinant Human TNF-Binding Protein-1 (RhTBP-1) Treatment Delays Both Symptoms Progression and Motor Neuron Loss in the Wobbler Mouse. Neurobiol. Dis. 2008;29:465&#x2013;476. doi: 10.1016/j.nbd.2007.11.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2007.11.005</ArticleId><ArticleId IdType="pubmed">18201889</ArticleId></ArticleIdList></Reference><Reference><Citation>Peviani M., Salvaneschi E., Bontempi L., Petese A., Manzo A., Rossi D., Salmona M., Collina S., Bigini P., Curti D. Neuroprotective Effects of the Sigma-1 Receptor (S1R) Agonist PRE-084, in a Mouse Model of Motor Neuron Disease Not Linked to SOD1 Mutation. Neurobiol. Dis. 2014;62:218&#x2013;232. doi: 10.1016/j.nbd.2013.10.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2013.10.010</ArticleId><ArticleId IdType="pubmed">24141020</ArticleId></ArticleIdList></Reference><Reference><Citation>Gargiulo-Monachelli G., Meyer M., Lara A., Garay L., Lima A., Roig P., De Nicola A.F., Gonzalez Deniselle M.C. Comparative Effects of Progesterone and the Synthetic Progestin Norethindrone on Neuroprotection in a Model of Spontaneous Motoneuron Degeneration. J. Steroid Biochem. Mol. Biol. 2019;192 doi: 10.1016/j.jsbmb.2019.105385.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jsbmb.2019.105385</ArticleId><ArticleId IdType="pubmed">31150830</ArticleId></ArticleIdList></Reference><Reference><Citation>De Paola M., Mariani A., Bigini P., Peviani M., Ferrara G., Molteni M., Gemma S., Veglianese P., Castellaneta V., Boldrin V., et al. Neuroprotective Effects of Toll-like Receptor 4 Antagonism in Spinal Cord Cultures and in a Mouse Model of Motor Neuron Degeneration. Mol. Med. 2012;18:971&#x2013;981. doi: 10.2119/molmed.2012.00020.</Citation><ArticleIdList><ArticleId IdType="doi">10.2119/molmed.2012.00020</ArticleId><ArticleId IdType="pmc">PMC3459480</ArticleId><ArticleId IdType="pubmed">22562723</ArticleId></ArticleIdList></Reference><Reference><Citation>Mennini T., De Paola M., Bigini P., Mastrotto C., Fumagalli E., Barbera S., Mengozzi M., Viviani B., Corsini E., Marinovich M., et al. Nonhematopoietic Erythropoietin Derivatives Prevent Motoneuron Degeneration in Vitro and in Vivo. Mol. Med. 2006;12:153&#x2013;160. doi: 10.2119/2006-00045.Mennini.</Citation><ArticleIdList><ArticleId IdType="doi">10.2119/2006-00045.Mennini</ArticleId><ArticleId IdType="pmc">PMC1626597</ArticleId><ArticleId IdType="pubmed">17088947</ArticleId></ArticleIdList></Reference><Reference><Citation>Meyer M., Gonzalez Deniselle M.C., Hunt H., De Kloet E.R., De Nicola A.F. The Selective Glucocorticoid Receptor Modulator CORT108297 Restores Faulty Hippocampal Parameters in Wobbler and Corticosterone-Treated Mice. J. Steroid Biochem. Mol. Biol. 2014;143:40&#x2013;48. doi: 10.1016/j.jsbmb.2014.02.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jsbmb.2014.02.007</ArticleId><ArticleId IdType="pubmed">24565565</ArticleId></ArticleIdList></Reference><Reference><Citation>Meyer M., Lara A., Hunt H., Belanoff J., de Kloet E.R., Gonzalez Deniselle M.C., De Nicola A.F. The Selective Glucocorticoid Receptor Modulator Cort 113176 Reduces Neurodegeneration and Neuroinflammation in Wobbler Mice Spinal Cord. Neuroscience. 2018;384:384&#x2013;396. doi: 10.1016/j.neuroscience.2018.05.042.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroscience.2018.05.042</ArticleId><ArticleId IdType="pubmed">29890290</ArticleId></ArticleIdList></Reference><Reference><Citation>Meyer M., Kruse M.S., Garay L., Lima A., Roig P., Hunt H., Belanoff J., de Kloet E.R., Deniselle M.C.G., De Nicola A.F. Long-Term Effects of the Glucocorticoid Receptor Modulator CORT113176 in Murine Motoneuron Degeneration. Brain Res. 2020;1727 doi: 10.1016/j.brainres.2019.146551.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2019.146551</ArticleId><ArticleId IdType="pubmed">31726042</ArticleId></ArticleIdList></Reference><Reference><Citation>Meyer M., Gonzalez Deniselle M.C., Garay L., Sitruk-Ware R., Guennoun R., Schumacher M., De Nicola A.F. The Progesterone Receptor Agonist Nestorone Holds Back Proinflammatory Mediators and Neuropathology in the Wobbler Mouse Model of Motoneuron Degeneration. Neuroscience. 2015;308:51&#x2013;63. doi: 10.1016/j.neuroscience.2015.09.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroscience.2015.09.007</ArticleId><ArticleId IdType="pubmed">26349009</ArticleId></ArticleIdList></Reference><Reference><Citation>Ransohoff R.M. A Polarizing Question: Do M1 and M2 Microglia Exist. Nat. Neurosci. 2016;19:987&#x2013;991. doi: 10.1038/nn.4338.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.4338</ArticleId><ArticleId IdType="pubmed">27459405</ArticleId></ArticleIdList></Reference><Reference><Citation>Kabba J.A., Xu Y., Christian H., Ruan W., Chenai K., Xiang Y., Zhang L., Saavedra J.M., Pang T. Microglia: Housekeeper of the Central Nervous System. Cell. Mol. Neurobiol. 2018;38:53&#x2013;71. doi: 10.1007/s10571-017-0504-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10571-017-0504-2</ArticleId><ArticleId IdType="pubmed">28534246</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao W., Beers D.R., Appel S.H. Immune-Mediated Mechanisms in the Pathoprogression of Amyotrophic Lateral Sclerosis. J. Neuroimmune Pharmacol. 2013;8:888&#x2013;899. doi: 10.1007/s11481-013-9489-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11481-013-9489-x</ArticleId><ArticleId IdType="pmc">PMC4126425</ArticleId><ArticleId IdType="pubmed">23881705</ArticleId></ArticleIdList></Reference><Reference><Citation>Henkel J.S., Engelhardt J.I., Sikl&#xf3;s L., Simpson E.P., Kim S.H., Pan T., Goodman J.C., Siddique T., Beers D.R., Appel S.H. Presence of Dendritic Cells, MCP-1, and Activated Microglia/Macrophages in Amyotrophic Lateral Sclerosis Spinal Cord Tissue. Ann. Neurol. 2004;55:221&#x2013;235. doi: 10.1002/ana.10805.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.10805</ArticleId><ArticleId IdType="pubmed">14755726</ArticleId></ArticleIdList></Reference><Reference><Citation>Corcia P., Tauber C., Vercoullie J., Arlicot N., Prunier C., Praline J., Nicolas G., Venel Y., Hommet C., Baulieu J.L., et al. Molecular Imaging of Microglial Activation in Amyotrophic Lateral Sclerosis. PLoS ONE. 2012;7 doi: 10.1371/journal.pone.0052941.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0052941</ArticleId><ArticleId IdType="pmc">PMC3534121</ArticleId><ArticleId IdType="pubmed">23300829</ArticleId></ArticleIdList></Reference><Reference><Citation>Turner M.R., Cagnin A., Turkheimer F.E., Miller C.C.J., Shaw C.E., Brooks D.J., Leigh P.N., Banati R.B. Evidence of Widespread Cerebral Microglial Activation in Amyotrophic Lateral Sclerosis: An [11C](R)-PK11195 Positron Emission Tomography Study. Neurobiol. Dis. 2004;15:601&#x2013;609. doi: 10.1016/j.nbd.2003.12.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2003.12.012</ArticleId><ArticleId IdType="pubmed">15056468</ArticleId></ArticleIdList></Reference><Reference><Citation>Evans M.C., Couch Y., Sibson N., Turner M.R. Inflammation and Neurovascular Changes in Amyotrophic Lateral Sclerosis. Mol. Cell. Neurosci. 2013;53:34&#x2013;41. doi: 10.1016/j.mcn.2012.10.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mcn.2012.10.008</ArticleId><ArticleId IdType="pubmed">23110760</ArticleId></ArticleIdList></Reference><Reference><Citation>Lewis C.A., Manning J., Rossi F., Krieger C. The Neuroinflammatory Response in ALS: The Roles of Microglia and T Cells. Neurol. Res. Int. 2012 doi: 10.1155/2012/803701.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2012/803701</ArticleId><ArticleId IdType="pmc">PMC3362167</ArticleId><ArticleId IdType="pubmed">22666587</ArticleId></ArticleIdList></Reference><Reference><Citation>Santiago A.R., Bernardino L., Agudo-Barriuso M., Gon&#xe7;alves J. Microglia in Health and Disease: A Double-Edged Sword. Mediat. Inflamm. 2017 doi: 10.1155/2017/7034143.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2017/7034143</ArticleId><ArticleId IdType="pmc">PMC5610790</ArticleId><ArticleId IdType="pubmed">29081602</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu J., Wang F. Role of Neuroinflammation in Amyotrophic Lateral Sclerosis: Cellular Mechanisms and Therapeutic Implications. Front. Immunol. 2017;8 doi: 10.3389/fimmu.2017.01005.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2017.01005</ArticleId><ArticleId IdType="pmc">PMC5567007</ArticleId><ArticleId IdType="pubmed">28871262</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Chalabi A., Van Den Berg L.H., Veldink J. Gene Discovery in Amyotrophic Lateral Sclerosis: Implications for Clinical Management. Nat. Rev. Neurol. 2017;13:96&#x2013;104. doi: 10.1038/nrneurol.2016.182.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneurol.2016.182</ArticleId><ArticleId IdType="pubmed">27982040</ArticleId></ArticleIdList></Reference><Reference><Citation>Zou Z.Y., Zhou Z.R., Che C.H., Liu C.Y., He R.L., Huang H.P. Genetic Epidemiology of Amyotrophic Lateral Sclerosis: A Systematic Review and Meta-Analysis. J. Neurol. Neurosurg. Psychiatry. 2017;88:540&#x2013;549. doi: 10.1136/jnnp-2016-315018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2016-315018</ArticleId><ArticleId IdType="pubmed">28057713</ArticleId></ArticleIdList></Reference><Reference><Citation>Bosco D.A., Morfini G., Karabacak N.M., Song Y., Gros-Louis F., Pasinelli P., Goolsby H., Fontaine B.A., Lemay N., McKenna-Yasek D., et al. Wild-Type and Mutant SOD1 Share an Aberrant Conformation and a Common Pathogenic Pathway in ALS. Nat. Neurosci. 2010;13:1396&#x2013;1403. doi: 10.1038/nn.2660.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.2660</ArticleId><ArticleId IdType="pmc">PMC2967729</ArticleId><ArticleId IdType="pubmed">20953194</ArticleId></ArticleIdList></Reference><Reference><Citation>Allen S., Heath P.R., Kirby J., Wharton S.B., Cookson M.R., Menzies F.M., Banks R.E., Shaw P.J. Analysis of the Cytosolic Proteome in a Cell Culture Model of Familial Amyotrophic Lateral Sclerosis Reveals Alterations to the Proteasome, Antioxidant Defenses, and Nitric Oxide Synthetic Pathways. J. Biol. Chem. 2003;278:6371&#x2013;6383. doi: 10.1074/jbc.M209915200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M209915200</ArticleId><ArticleId IdType="pubmed">12475980</ArticleId></ArticleIdList></Reference><Reference><Citation>Heiman-Patterson T.D., Sher R.B., Blankenhorn E.A., Alexander G., Deitch J.S., Kunst C.B., Maragakis N., Cox G. Effect of Genetic Background on Phenotype Variability in Transgenic Mouse Models of Amyotrophic Lateral Sclerosis: A Window of Opportunity in the Search for Genetic Modifiers. Amyotroph. Lateral Scler. 2011;12:79&#x2013;86. doi: 10.3109/17482968.2010.550626.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/17482968.2010.550626</ArticleId><ArticleId IdType="pubmed">21241159</ArticleId></ArticleIdList></Reference><Reference><Citation>Nardo G., Trolese M.C., Tortarolo M., Vallarola A., Freschi M., Pasetto L., Bonetto V., Bendotti C. New Insights on the Mechanisms of Disease Course Variability in ALS from Mutant SOD1 Mouse Models. Brain Pathol. 2016;26:237&#x2013;247. doi: 10.1111/bpa.12351.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bpa.12351</ArticleId><ArticleId IdType="pubmed">26780365</ArticleId></ArticleIdList></Reference><Reference><Citation>Nardo G., Trolese M.C., de Vito G., Cecchi R., Riva N., Dina G., Heath P.R., Quattrini A., Shaw P.J., Piazza V., et al. Immune Response in Peripheral Axons Delays Disease Progression in SOD1G93A Mice. J. Neuroinflamm. 2016;13 doi: 10.1186/s12974-016-0732-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-016-0732-2</ArticleId><ArticleId IdType="pmc">PMC5055725</ArticleId><ArticleId IdType="pubmed">27717377</ArticleId></ArticleIdList></Reference><Reference><Citation>Marino M., Papa S., Crippa V., Nardo G., Peviani M., Cheroni C., Trolese M.C., Lauranzano E., Bonetto V., Poletti A., et al. Differences in Protein Quality Control Correlate with Phenotype Variability in 2 Mouse Models of Familial Amyotrophic Lateral Sclerosis. Neurobiol. Aging. 2015;36:492&#x2013;504. doi: 10.1016/j.neurobiolaging.2014.06.026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2014.06.026</ArticleId><ArticleId IdType="pubmed">25085783</ArticleId></ArticleIdList></Reference><Reference><Citation>Turner B.J., Talbot K. Transgenics, Toxicity and Therapeutics in Rodent Models of Mutant SOD1-Mediated Familial ALS. Prog. Neurobiol. 2008;85:94&#x2013;134. doi: 10.1016/j.pneurobio.2008.01.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pneurobio.2008.01.001</ArticleId><ArticleId IdType="pubmed">18282652</ArticleId></ArticleIdList></Reference><Reference><Citation>Gurney M.E., Pu H., Chiu A.Y., Dal Canto M.C., Polchow C.Y., Alexander D.D., Caliendo J., Hentati A., Kwon Y.W., Deng H.X., et al. Motor Neuron Degeneration in Mice That Express a Human Cu, Zn Superoxide Dismutase Mutation. Science. 1994;264:1772&#x2013;1775. doi: 10.1126/science.8209258.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.8209258</ArticleId><ArticleId IdType="pubmed">8209258</ArticleId></ArticleIdList></Reference><Reference><Citation>Foyez T., Takeda-Uchimura Y., Ishigaki S., Narentuya N., Zhang Z., Sobue G., Kadomatsu K., Uchimura K. Microglial Keratan Sulfate Epitope Elicits in Central Nervous Tissues of Transgenic Model Mice and Patients with Amyotrophic Lateral Sclerosis. Am. J. Pathol. 2015;185:3053&#x2013;3065. doi: 10.1016/j.ajpath.2015.07.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajpath.2015.07.016</ArticleId><ArticleId IdType="pubmed">26362733</ArticleId></ArticleIdList></Reference><Reference><Citation>Ohgomori T., Yamasaki R., Takeuchi H., Kadomatsu K., Kira J.I., Jinno S. Differential Activation of Neuronal and Glial STAT3 in the Spinal Cord of the SOD1G93A Mouse Model of Amyotrophic Lateral Sclerosis. Eur. J. Neurosci. 2017;46:2001&#x2013;2014. doi: 10.1111/ejn.13650.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ejn.13650</ArticleId><ArticleId IdType="pubmed">28715117</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitsui S., Otomo A., Nozaki M., Ono S., Sato K., Shirakawa R., Adachi H., Aoki M., Sobue G., Shang H.F., et al. Systemic Overexpression of SQSTM1/P62 Accelerates Disease Onset in a SOD1H46R-Expressing ALS Mouse Model. Mol. Brain. 2018;11 doi: 10.1186/s13041-018-0373-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13041-018-0373-8</ArticleId><ArticleId IdType="pmc">PMC5975400</ArticleId><ArticleId IdType="pubmed">29843805</ArticleId></ArticleIdList></Reference><Reference><Citation>Trias E., Ibarburu S., Barreto-N&#xfa;&#xf1;ez R., Babdor J., Maciel T.T., Guillo M., Gros L., Dubreuil P., D&#xed;az-Amarilla P., Cassina P., et al. Post-Paralysis Tyrosine Kinase Inhibition with Masitinib Abrogates Neuroinflammation and Slows Disease Progression in Inherited Amyotrophic Lateral Sclerosis. J. Neuroinflamm. 2016:13. doi: 10.1186/s12974-016-0620-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-016-0620-9</ArticleId><ArticleId IdType="pmc">PMC4940876</ArticleId><ArticleId IdType="pubmed">27400786</ArticleId></ArticleIdList></Reference><Reference><Citation>Deora V., Lee J.D., Albornoz E.A., McAlary L., Jagaraj C.J., Robertson A.A.B., Atkin J.D., Cooper M.A., Schroder K., Yerbury J.J., et al. The Microglial NLRP3 Inflammasome Is Activated by Amyotrophic Lateral Sclerosis Proteins. Glia. 2020;68:407&#x2013;421. doi: 10.1002/glia.23728.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/glia.23728</ArticleId><ArticleId IdType="pubmed">31596526</ArticleId></ArticleIdList></Reference><Reference><Citation>Silverman J.M., Christy D., Shyu C.C., Moon K.M., Fernando S., Gidden Z., Cowan C.M., Ban Y., Greg Stacey R., Grad L.I., et al. CNS-Derived Extracellular Vesicles from Superoxide Dismutase 1 (SOD1)G93A ALS Mice Originate from Astrocytes and Neurons and Carry Misfolded SOD1. J. Biol. Chem. 2019;294:3744&#x2013;3759. doi: 10.1074/jbc.RA118.004825.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.RA118.004825</ArticleId><ArticleId IdType="pmc">PMC6416428</ArticleId><ArticleId IdType="pubmed">30635404</ArticleId></ArticleIdList></Reference><Reference><Citation>Kassa R.M., Bonafede R., Boschi F., Bentivoglio M., Mariotti R. Effect of Physical Exercise and Anabolic Steroid Treatment on Spinal Motoneurons and Surrounding Glia of Wild-Type and ALS Mice. Brain Res. 2017;1657:269&#x2013;278. doi: 10.1016/j.brainres.2016.12.029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2016.12.029</ArticleId><ArticleId IdType="pubmed">28048973</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang J., Liu Y., Liu X., Li S., Cheng C., Chen S., Le W. Dynamic Changes of CX3CL1/CX3CR1 Axis during Microglial Activation and Motor Neuron Loss in the Spinal Cord of ALS Mouse Model. Transl. Neurodegener. 2018;7 doi: 10.1186/s40035-018-0138-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40035-018-0138-4</ArticleId><ArticleId IdType="pmc">PMC6309063</ArticleId><ArticleId IdType="pubmed">30607245</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang J., Liang H., Zhu L., Gan W., Tang C., Li J., Xu R. Expression and Distribution of Arylsulfatase B Are Closely Associated with Neuron Death in SOD1 G93A Transgenic Mice. Mol. Neurobiol. 2018;55:1323&#x2013;1337. doi: 10.1007/s12035-017-0406-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-017-0406-9</ArticleId><ArticleId IdType="pubmed">28124772</ArticleId></ArticleIdList></Reference><Reference><Citation>Shijo T., Warita H., Suzuki N., Ikeda K., Mitsuzawa S., Akiyama T., Ono H., Nishiyama A., Izumi R., Kitajima Y., et al. Antagonizing Bone Morphogenetic Protein 4 Attenuates Disease Progression in a Rat Model of Amyotrophic Lateral Sclerosis. Exp. Neurol. 2018;307:164&#x2013;179. doi: 10.1016/j.expneurol.2018.06.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2018.06.009</ArticleId><ArticleId IdType="pubmed">29932880</ArticleId></ArticleIdList></Reference><Reference><Citation>Han G., Li F., Singh T.P., Wolf P., Wang X.J. The Pro-Inflammatory Role of TGF&#x3b2;1: A Paradox? Int. J. Biol. Sci. 2012;8:28&#x2013;235. doi: 10.7150/ijbs.8.228.</Citation><ArticleIdList><ArticleId IdType="doi">10.7150/ijbs.8.228</ArticleId><ArticleId IdType="pmc">PMC3258562</ArticleId><ArticleId IdType="pubmed">22253566</ArticleId></ArticleIdList></Reference><Reference><Citation>Epperly M.W., Fisher R., Rigatti L., Watkins S., Zhang X., Hou W., Shields D., Franicola D., Bayir H., Wang H., et al. Amelioration of Amyotrophic Lateral Sclerosis in SOD1G93A Mice by M2 Microglia from Transplanted Marrow. In Vivo. 2019;33:675&#x2013;688. doi: 10.21873/invivo.11526.</Citation><ArticleIdList><ArticleId IdType="doi">10.21873/invivo.11526</ArticleId><ArticleId IdType="pmc">PMC6559904</ArticleId><ArticleId IdType="pubmed">31028184</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu W., Venugopal S., Majid S., Ahn I.S., Diamante G., Hong J., Yang X., Chandler S.H. Single-Cell RNA-Seq Analysis of the Brainstem of Mutant SOD1 Mice Reveals Perturbed Cell Types and Pathways of Amyotrophic Lateral Sclerosis. Neurobiol. Dis. 2020;141 doi: 10.1016/j.nbd.2020.104877.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2020.104877</ArticleId><ArticleId IdType="pmc">PMC7519882</ArticleId><ArticleId IdType="pubmed">32360664</ArticleId></ArticleIdList></Reference><Reference><Citation>Krasemann S., Madore C., Cialic R., Baufeld C., Calcagno N., El Fatimy R., Beckers L., O&#x2019;Loughlin E., Xu Y., Fanek Z., et al. The TREM2-APOE Pathway Drives the Transcriptional Phenotype of Dysfunctional Microglia in Neurodegenerative Diseases. Immunity. 2017;47:566&#x2013;581.e9. doi: 10.1016/j.immuni.2017.08.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2017.08.008</ArticleId><ArticleId IdType="pmc">PMC5719893</ArticleId><ArticleId IdType="pubmed">28930663</ArticleId></ArticleIdList></Reference><Reference><Citation>Noristani H.N., Sabourin J.C., Gerber Y.N., Teigell M., Sommacal A., Vivanco M.D.M., Weber M., Perrin F.E. Brca1 Is Expressed in Human Microglia and Is Dysregulated in Human and Animal Model of ALS. Mol. Neurodegener. 2015;10 doi: 10.1186/s13024-015-0023-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13024-015-0023-x</ArticleId><ArticleId IdType="pmc">PMC4521418</ArticleId><ArticleId IdType="pubmed">26227626</ArticleId></ArticleIdList></Reference><Reference><Citation>Renton A.E., Chi&#xf2; A., Traynor B.J. State of Play in Amyotrophic Lateral Sclerosis Genetics. Nat. Neurosci. 2014;17:17&#x2013;23. doi: 10.1038/nn.3584.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.3584</ArticleId><ArticleId IdType="pmc">PMC4544832</ArticleId><ArticleId IdType="pubmed">24369373</ArticleId></ArticleIdList></Reference><Reference><Citation>Taylor J.P., Brown R.H., Cleveland D.W. Decoding ALS: From Genes to Mechanism. Nature. 2016;539:197&#x2013;206. doi: 10.1038/nature20413.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature20413</ArticleId><ArticleId IdType="pmc">PMC5585017</ArticleId><ArticleId IdType="pubmed">27830784</ArticleId></ArticleIdList></Reference><Reference><Citation>Lutz C. Mouse Models of ALS: Past, Present and Future. Brain Res. 2018;1693:1&#x2013;10. doi: 10.1016/j.brainres.2018.03.024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2018.03.024</ArticleId><ArticleId IdType="pubmed">29577886</ArticleId></ArticleIdList></Reference><Reference><Citation>DeJesus-Hernandez M., Mackenzie I.R., Boeve B.F., Boxer A.L., Baker M., Rutherford N.J., Nicholson A.M., Finch N.C.A., Flynn H., Adamson J., et al. Expanded GGGGCC Hexanucleotide Repeat in Noncoding Region of C9ORF72 Causes Chromosome 9p-Linked FTD and ALS. Neuron. 2011;72:245&#x2013;256. doi: 10.1016/j.neuron.2011.09.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2011.09.011</ArticleId><ArticleId IdType="pmc">PMC3202986</ArticleId><ArticleId IdType="pubmed">21944778</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen H., Kankel M.W., Su S.C., Han S.W.S., Ofengeim D. Exploring the Genetics and Non-Cell Autonomous Mechanisms Underlying ALS/FTLD. Cell Death Differ. 2018;25:646&#x2013;660. doi: 10.1038/s41418-018-0060-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41418-018-0060-4</ArticleId><ArticleId IdType="pmc">PMC5864209</ArticleId><ArticleId IdType="pubmed">29459769</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Rourke J.G., Bogdanik L., Y&#xe1;&#xf1;ez A., Lall D., Wolf A.J., Muhammad A.K.M.G., Ho R., Carmona S., Vit J.P., Zarrow J., et al. C9orf72 Is Required for Proper Macrophage and Microglial Function in Mice. Science. 2016;351:1324&#x2013;1329. doi: 10.1126/science.aaf1064.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aaf1064</ArticleId><ArticleId IdType="pmc">PMC5120541</ArticleId><ArticleId IdType="pubmed">26989253</ArticleId></ArticleIdList></Reference><Reference><Citation>Chew J., Gendron T.F., Prudencio M., Sasaguri H., Zhang Y.J., Castanedes-Casey M., Lee C.W., Jansen-West K., Kurti A., Murray M.E., et al. C9ORF72 Repeat Expansions in Mice Cause TDP-43 Pathology, Neuronal Loss, and Behavioral Deficits. Science. 2015;348:1151&#x2013;1154. doi: 10.1126/science.aaa9344.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aaa9344</ArticleId><ArticleId IdType="pmc">PMC4692360</ArticleId><ArticleId IdType="pubmed">25977373</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Rourke J.G., Bogdanik L., Muhammad A.K.M.G., Gendron T.F., Kim K.J., Austin A., Cady J., Liu E.Y., Zarrow J., Grant S., et al. C9orf72 BAC Transgenic Mice Display Typical Pathologic Features of ALS/FTD. Neuron. 2015;88:892&#x2013;901. doi: 10.1016/j.neuron.2015.10.027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2015.10.027</ArticleId><ArticleId IdType="pmc">PMC4672384</ArticleId><ArticleId IdType="pubmed">26637796</ArticleId></ArticleIdList></Reference><Reference><Citation>Peters O.M., Cabrera G.T., Tran H., Gendron T.F., McKeon J.E., Metterville J., Weiss A., Wightman N., Salameh J., Kim J., et al. Human C9ORF72 Hexanucleotide Expansion Reproduces RNA Foci and Dipeptide Repeat Proteins but Not Neurodegeneration in BAC Transgenic Mice. Neuron. 2015;88:902&#x2013;909. doi: 10.1016/j.neuron.2015.11.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2015.11.018</ArticleId><ArticleId IdType="pmc">PMC4828340</ArticleId><ArticleId IdType="pubmed">26637797</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y., Pattamatta A., Zu T., Reid T., Bardhi O., Borchelt D.R., Yachnis A.T., Ranum L.P.W. C9orf72 BAC Mouse Model with Motor Deficits and Neurodegenerative Features of ALS/FTD. Neuron. 2016;90:521&#x2013;534. doi: 10.1016/j.neuron.2016.04.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2016.04.005</ArticleId><ArticleId IdType="pubmed">27112499</ArticleId></ArticleIdList></Reference><Reference><Citation>Batra R., Lee C.W. Mouse Models of C9orf72 Hexanucleotide Repeat Expansion in Amyotrophic Lateral Sclerosis/ Frontotemporal Dementia. Front. Cell. Neurosci. 2017;11 doi: 10.3389/fncel.2017.00196.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2017.00196</ArticleId><ArticleId IdType="pmc">PMC5498553</ArticleId><ArticleId IdType="pubmed">28729824</ArticleId></ArticleIdList></Reference><Reference><Citation>Langseth A.J., Kim J., Ugolino J.E., Shah Y., Hwang H.Y., Wang J., Bergles D.E., Brown S.P. Cell-Type Specific Differences in Promoter Activity of the ALS-Linked C9orf72 Mouse Ortholog. Sci. Rep. 2017;7 doi: 10.1038/s41598-017-05864-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-017-05864-2</ArticleId><ArticleId IdType="pmc">PMC5515847</ArticleId><ArticleId IdType="pubmed">28720882</ArticleId></ArticleIdList></Reference><Reference><Citation>Nicholson A.M., Zhou X., Perkerson R.B., Parsons T.M., Chew J., Brooks M., DeJesus-Hernandez M., Finch N.C.A., Matchett B.J., Kurti A., et al. Loss of Tmem106b Is Unable to Ameliorate Frontotemporal Dementia-like Phenotypes in an AAV Mouse Model of C9ORF72-Repeat Induced Toxicity. Acta Neuropathol. Commun. 2018;6:42. doi: 10.1186/s40478-018-0545-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-018-0545-x</ArticleId><ArticleId IdType="pmc">PMC5984311</ArticleId><ArticleId IdType="pubmed">29855382</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y.J., Gendron T.F., Grima J.C., Sasaguri H., Jansen-West K., Xu Y.F., Katzman R.B., Gass J., Murray M.E., Shinohara M., et al. C9ORF72 Poly(GA) Aggregates Sequester and Impair HR23 and Nucleocytoplasmic Transport Proteins. Nat. Neurosci. 2016;19:668&#x2013;677. doi: 10.1038/nn.4272.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.4272</ArticleId><ArticleId IdType="pmc">PMC5138863</ArticleId><ArticleId IdType="pubmed">26998601</ArticleId></ArticleIdList></Reference><Reference><Citation>Lagier-Tourenne C., Baughn M., Rigo F., Sun S., Liu P., Li H.R., Jiang J., Watt A.T., Chun S., Katz M., et al. Targeted Degradation of Sense and Antisense C9orf72 RNA Foci as Therapy for ALS and Frontotemporal Degeneration. Proc. Natl. Acad. Sci. USA. 2013;110 doi: 10.1073/pnas.1318835110.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1318835110</ArticleId><ArticleId IdType="pmc">PMC3839752</ArticleId><ArticleId IdType="pubmed">24170860</ArticleId></ArticleIdList></Reference><Reference><Citation>Benajiba L., Le Ber I., Camuzat A., Lacoste M., Thomas-Anterion C., Couratier P., Legallic S., Salachas F., Hannequin D., Decousus M., et al. TARDBP Mutations in Motoneuron Disease with Frontotemporal Lobar Degeneration. Ann. Neurol. 2009;65:470&#x2013;473. doi: 10.1002/ana.21612.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.21612</ArticleId><ArticleId IdType="pubmed">19350673</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee E.B., Lee V.M.Y., Trojanowski J.Q. Gains or Losses: Molecular Mechanisms of TDP43-Mediated Neurodegeneration. Nat. Rev. Neurosci. 2012;13:38&#x2013;50. doi: 10.1038/nrn3121.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrn3121</ArticleId><ArticleId IdType="pmc">PMC3285250</ArticleId><ArticleId IdType="pubmed">22127299</ArticleId></ArticleIdList></Reference><Reference><Citation>Neumann M., Sampathu D.M., Kwong L.K., Truax A.C., Micsenyi M.C., Chou T.T., Bruce J., Schuck T., Grossman M., Clark C.M., et al. Ubiquitinated TDP-43 in Frontotemporal Lobar Degeneration and Amyotrophic Lateral Sclerosis. Science. 2006;314:130&#x2013;133. doi: 10.1126/science.1134108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1134108</ArticleId><ArticleId IdType="pubmed">17023659</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang H., Tan C.F., Mori F., Tanji K., Kakita A., Takahashi H., Wakabayashi K. TDP-43-Immunoreactive Neuronal and Glial Inclusions in the Neostriatum in Amyotrophic Lateral Sclerosis with and without Dementia. Acta Neuropathol. 2008;115:115&#x2013;122. doi: 10.1007/s00401-007-0285-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-007-0285-7</ArticleId><ArticleId IdType="pubmed">17786458</ArticleId></ArticleIdList></Reference><Reference><Citation>McGoldrick P., Joyce P.I., Fisher E.M.C., Greensmith L. Rodent Models of Amyotrophic Lateral Sclerosis. Biochim. Biophys. Acta Mol. Basis Dis. 2013;1832:1421&#x2013;1436. doi: 10.1016/j.bbadis.2013.03.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbadis.2013.03.012</ArticleId><ArticleId IdType="pubmed">23524377</ArticleId></ArticleIdList></Reference><Reference><Citation>Dutta K., Patel P., Rahimian R., Phaneuf D., Julien J.P. Withania Somnifera Reverses Transactive Response DNA Binding Protein 43 Proteinopathy in a Mouse Model of Amyotrophic Lateral Sclerosis/Frontotemporal Lobar Degeneration. Neurotherapeutics. 2017;14:447&#x2013;462. doi: 10.1007/s13311-016-0499-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13311-016-0499-2</ArticleId><ArticleId IdType="pmc">PMC5398980</ArticleId><ArticleId IdType="pubmed">27928708</ArticleId></ArticleIdList></Reference><Reference><Citation>Correia A.S., Patel P., Dutta K., Julien J.P. Inflammation Induces TDP-43 Mislocalization and Aggregation. PLoS ONE. 2015;10 doi: 10.1371/journal.pone.0140248.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0140248</ArticleId><ArticleId IdType="pmc">PMC4596857</ArticleId><ArticleId IdType="pubmed">26444430</ArticleId></ArticleIdList></Reference><Reference><Citation>Falconer D.S. Wobbler (Wr) Mouse News Lett. 1956;15:22.</Citation></Reference><Reference><Citation>Schmitt-John T., Drepper C., Mu&#xdf;mann A., Hahn P., Kuhlmann M., Thiel C., Hafner M., Lengeling A., Heimann P., Jones J.M., et al. Mutation of Vps54 Causes Motor Neuron Disease and Defective Spermiogenesis in the Wobbler Mouse. Nat. Genet. 2005;37:1213&#x2013;1215. doi: 10.1038/ng1661.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng1661</ArticleId><ArticleId IdType="pubmed">16244655</ArticleId></ArticleIdList></Reference><Reference><Citation>Boill&#xe9;e S., Peschanski M., Junier M.P. The Wobbler Mouse: A Neurodegeneration Jigsaw Puzzle. Mol. Neurobiol. 2003;28:65&#x2013;106. doi: 10.1385/MN:28:1:65.</Citation><ArticleIdList><ArticleId IdType="doi">10.1385/MN:28:1:65</ArticleId><ArticleId IdType="pubmed">14514986</ArticleId></ArticleIdList></Reference><Reference><Citation>Moser J.M., Bigini P., Schmitt-John T. The Wobbler Mouse, an ALS Animal Model. Mol. Genet. Genom. 2013;288:207&#x2013;229. doi: 10.1007/s00438-013-0741-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00438-013-0741-0</ArticleId><ArticleId IdType="pmc">PMC3664746</ArticleId><ArticleId IdType="pubmed">23539154</ArticleId></ArticleIdList></Reference><Reference><Citation>Cipollina G., Serej A.D., Di Nolfi G., Gazzano A., Marsala A., Spatafora M.G., Peviani M. Heterogeneity of Neuroinflammatory Responses in Amyotrophic Lateral Sclerosis: A Challenge or an Opportunity? Int. J. Mol. Sci. 2020;21:7923. doi: 10.3390/ijms21217923.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms21217923</ArticleId><ArticleId IdType="pmc">PMC7662281</ArticleId><ArticleId IdType="pubmed">33113845</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>